Studies showed that TGF-β regulates the cancer stem cell self-renewal and differentiation properties via inducing leukemia inhibitory factor (LIF) and IL-11 activation of the JAK/STAT pathway and STAT3 phosphorylation in glioblastoma and colon cancer, respectively. This evidence concerns the gene IL11 and colonic neoplasm.